AgomAb Therapeutics NV (AGMB)

AgomAb Therapeutics NV Statistics

Total Valuation

AGMB has a market cap or net worth of $790.02 million. The enterprise value is $639.54 million.

Market Cap	790.02M
Enterprise Value	639.54M

Important Dates

The next estimated earnings date is Tuesday, June 16, 2026.

Earnings Date	Jun 16, 2026
Ex-Dividend Date	n/a

Share Statistics

AGMB has 48.74 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	48.74M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	16.15%
Float	21.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.58
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.99, with a Debt / Equity ratio of 0.01.

Current Ratio	13.99
Quick Ratio	13.63
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,240.05

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-34.95%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.47M
Employee Count	58
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, AGMB has paid $4,693 in taxes.

Income Tax	4,693
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	66.20
Average Volume (20 Days)	291,149

Short Selling Information

The latest short interest is 118,033, so 0.24% of the outstanding shares have been sold short.

Short Interest	118,033
Short Previous Month	n/a
Short % of Shares Out	0.24%
Short % of Float	0.54%
Short Ratio (days to cover)	0.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-64.02M
Pretax Income	-66.73M
Net Income	-84.79M
EBITDA	-63.86M
EBIT	-64.02M
Earnings Per Share (EPS)	-$3,391.53

Balance Sheet

The company has $152.04 million in cash and $1.56 million in debt, with a net cash position of $150.48 million or $3.09 per share.

Cash & Cash Equivalents	152.04M
Total Debt	1.56M
Net Cash	150.48M
Net Cash Per Share	$3.09
Equity (Book Value)	172.39M
Book Value Per Share	-7,168.84
Working Capital	144.91M

Cash Flow

In the last 12 months, operating cash flow was -$59.85 million and capital expenditures -$425,906, giving a free cash flow of -$59.62 million.

Operating Cash Flow	-59.85M
Capital Expenditures	-425,906
Free Cash Flow	-59.62M
FCF Per Share	-$1.22

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AGMB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-10.73%
FCF Yield	-7.55%

Analyst Forecast

The average price target for AGMB is $28.00, which is 72.73% higher than the current price. The consensus rating is "Buy".

Price Target	$28.00
Price Target Difference	72.73%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1